La Jolla Pharmaceutical Company Releases Data Indicating GCS-100 May Improve Renal Function
SAN DIEGO, CA--(Marketwired - May 23, 2013) - La Jolla Pharmaceutical Company (OTCBB: LJPC) ("La Jolla" and "Company"), a leader in the development of therapeutics targeting galectin proteins...(more)
La Jolla Pharmaceutical Company
May 23, 2013 15:37 ET